Somatostatin receptor expression in hepatocellular carcinoma: prognostic and therapeutic considerations
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Somatostatin receptor expression in hepatocellular carcinoma: prognostic and therapeutic considerations
Authors
Keywords
-
Journal
ENDOCRINE-RELATED CANCER
Volume 21, Issue 6, Pages R485-R493
Publisher
Bioscientifica
Online
2014-10-22
DOI
10.1530/erc-14-0389
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Significance of Joint Detection of Serum VEGF, SIL-2R and HGF in Patients with Primary Hepatocellular Carcinoma before and after Percutaneous Microwave Coagulation Therapy
- (2014) Ji-Dong Chen et al. Asian Pacific Journal of Cancer Prevention
- Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC)
- (2012) Joong-Won Park et al. LIVER INTERNATIONAL
- Epidemiology and Surveillance of Hepatocellular Carcinoma
- (2012) Do Young Kim et al. Liver Cancer
- Post-TACE Combination Therapy of Heparin and Octreotide Results in Decreased Tumor Metastasis in Extrahepatic Tumorigenesis
- (2011) Weidong Jia et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Somatostatin receptor scintigraphy screening in advanced hepatocarcinoma: A multicenter French study
- (2010) Eric Nguyen-Khac et al. CANCER BIOLOGY & THERAPY
- Sorafenib plus octreotide is an effective and safe treatment in advanced hepatocellular carcinoma: multicenter phase II So.LAR. study
- (2009) Salvatore Del Prete et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Treatment of advanced hepatocellular carcinoma with long-acting octreotide: A phase III multicentre, randomised, double blind placebo-controlled study
- (2009) Jean-Claude Barbare et al. EUROPEAN JOURNAL OF CANCER
- Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
- (2009) Anja Rinke et al. JOURNAL OF CLINICAL ONCOLOGY
- Octreotide treatment of patients with hepatocellular carcinoma - a retrospective single centre controlled study
- (2009) Maximilian Schöniger-Hekele et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- A Somatostatin Analogue, Octreotide, Inhibits the Occurrence of Second Primary Tumors and Lung Metastasis after Resection of Hepatocellular Carcinoma in Mice
- (2009) Wei-Dong Jia et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- Somatostatin Receptor in Human Hepatocellular Carcinomas: Biological, Patient and Tumor Characteristics
- (2008) C. Verhoef et al. DIGESTIVE SURGERY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Adenylyl Cyclase/cAMP System Involvement in the Antiangiogenic Effect of Somatostatin in the Retina. Results from Transgenic Mice
- (2008) Chiara Ristori et al. NEUROCHEMICAL RESEARCH
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search